| Market Cap | ₹103Cr |
| ROE | 24.80% |
| P/E Ratio(TTM) | 11.06 |
| EPS(TTM) | 8.66 |
| P/B Ratio | 2.86 |
| Dividend Yield | 0.00% |
| Industry P/E | 40.62 |
| Book Value | 33.43 |
| Debt to Equity | 0.37 |
| Face Value | 10 |
| Parent Organisation | Astal Laboratories |
| BSE Symbol | 512600 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |